Health professionals get stronger say
EMA Highlights by Gary Finnegan – A new Healthcare Professionals’ Working Party (HCPWP) has been created by the European Medicines Agency in an effort to secure greater input… read more.
EMA Highlights by Gary Finnegan – A new Healthcare Professionals’ Working Party (HCPWP) has been created by the European Medicines Agency in an effort to secure greater input… read more.
EMA Highlights by Gary Finnegan – The European Medicines Agency (EMA) must perform a delicate balancing act as it finds itself centre stage in the on-going debate about… read more.
FDA Highlights by Bruce Sylvester – Researchers report that, in a double-blind trial involving clinically depressed patients who had not responded to at least three prior antidepressants, intravenous… read more.
FDA Highlights by Bruce Sylvester – Treatment with the antipsycotic drug haloperidol does not reduce symptoms of delirium in critically ill patients, UK researchers report.
FDA Highlights by Bruce Sylvester – Researchers report from a phase I clinical trial report that diffuse, large B-cell lymphomas (DLBCLs) resistant to chemotherapy have been successfully reprogrammed… read more.
FDA Highlights by Bruce Sylvester – Misoprostol vaginal insert used for labor induction has significantly reduced time to vaginal delivery compared with dinoprostone vaginal insert, researchers reported at… read more.
Similar trends found in UK, Australia and US. Missed diagnoses―particularly of cancer, heart attack, and meningitis―and drug errors make up the bulk of malpractice claims brought against doctors… read more.
Children whose mothers took antiepileptic drugs (AEDs) while pregnant are at increased risk of early development issues, according to a new study published in Epilepsia, a journal published by… read more.
Taken from the Lancet – by Bruce Sylvester – High doses of some non-steroidal anti-inflammatory drugs (NSAIDs) increase the risk of major vascular events (non-fatal heart attacks, strokes,… read more.
FDA Highlights by Bruce Sylvester – Lexapro (escitalopram), which is used to treat depression and anxiety, appears to improve a stress-related heart condition in persons with stable coronary… read more.
FDA Highlights by Bruce Sylvester – Researchers report that finasteride appears to reduce alcohol consumption in some men. The results were published online on June 13, 2013 by Alcoholism:… read more.
FDA Highlights by Bruce Sylvester – Bazedoxifene, approved in Europe to treat osteoporosis, appears to stop the growth of breast cancer cells, even in therapy-resistant tumors, researchers from… read more.
Advertisment
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.